M Schartl

RANDOMISED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION

M Verstraete, M Bory, D Collen et al. · The Lancet · 1985 · 752 citations

Thrombosis, Cardiovascular Disease, Fibrinolysis +10

Use of Intravascular Ultrasound to Compare Effects of Different Strategies of Lipid-Lowering Therapy on Plaque Volume and Composition in Patients With Coronary Artery Disease

M Schartl, Wolfgang Bocksch, Dietmar Koschyk et al. · Circulation · 2001 · 366 citations · Full text

Effect of Intensive Versus Standard Lipid-Lowering Treatment With Atorvastatin on the Progression of Calcified Coronary Atherosclerosis Over 12 Months

Axel Schmermund, Stephan Achenbach, Thomas Budde et al. · Circulation · 2006 · 253 citations · Full text

Changes in left ventricular function after intracoronary streptokinase infusion in clinically evolving myocardial infarction

P. Rentrop, H. Blanke, K. R. Karsch et al. · American Heart Journal · 1981 · 125 citations

Heart Failure, Intracoronary Streptokinase Infusion, Cardiogenic Shock +7

Acute coronary thrombolysis with recombinant human tissue-type plasminogen activator: Initial patency and influence of maintained infusion on reocclusion rate

Marc Verstraete, Alfred Arnold, Ronald W. Brower et al. · The American Journal of Cardiology · 1987 · 115 citations · Full text

Percutaneous Coronary Intervention, Thrombosis, Acute Coronary Thrombolysis +13